Biotech

All Articles

iTeos- GSK's TIGIT superstar reveals significant renovation

.After revealing a stage 3 launch based upon favorable midstage results, iTeos and also GSK are even...

More collective FDA can easily increase unusual ailment R&ampD: file

.The FDA should be actually a lot more available as well as joint to discharge a surge in commendati...

Zenas, MBX, Bicara head to Nasdaq in warm time for biotech IPOs

.It is actually an uncommonly active Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bic...

Atea's COVID antiviral fails to halt hospital stays in phase 3

.Atea Pharmaceuticals' antiviral has actually stopped working another COVID-19 test, but the biotech...

Neurocrine's proposal to conserve mental illness prospect falls short

.Neurocrine Biosciences' schizophrenia system pivot has actually stopped working. The biotech was ac...

Sanofi spends $110M upfront for late-stage radioligand therapy

.Sanofi has brought in an overdue entry to the radioligand party, spending one hundred thousand euro...

F 2G increases $100M for second try to get new antifungal to market

.After F2G's first try to receive a brand-new training class of antifungal to market was actually wr...

Moderna targets $1.1 B in R&ampD investing cuts, drops 5 plans amidst success stress

.Moderna has actually sworn to reduce R&ampD spending through $1.1 billion through 2027. The choice ...

Sanofi's $80M bank on Pivot dystrophy medicine ends in phase 3 fail

.Only four months after Sanofi wager $80 million in beforehand money on Pivot Therapies' losmapimod,...

Oncternal equity sinks 60% among layoffs, test firings

.Cancer cells provider Oncternal Rehabs is actually folding all its clinical trials as well as layin...